TGA launches codeine safety review

A review on the efficacy and safety of codeine will be undertaken to help determine whether the pain relief drug should be reclassified to prescription only. Speaking during a Senate hearing Head of the TGA Professor John Skeritt said the information gathered from the review would feed into any final decision that was likely to ...

Already a member?

Login to keep reading.

© 2021 the limbic